effusion. Chest X-Ray (PA view) also shows a moderate pleural effusion. A diagnostic
thoracocentesis reveals straw coloured exudates with 50 mg% of sugar and lymphocytic
pleocytosis. ADA levels are borderline. What investigation would be most likely to confirm a
diagnosis of tuberculosis?
The patient presents with symptoms (fever, chest pain) and findings (moderate right-sided pleural effusion) suggestive of pleural inflammation. The pleural fluid analysis shows an exudate with lymphocytic predominance, low sugar concentration (approximately 50 mg%), and borderline Adenosine Deaminase (ADA) levels. These features are characteristic of tuberculous pleurisy, but they are not exclusively diagnostic.
Several investigations can help confirm tuberculosis (TB) in this context:
While Xpert MTB/RIF offers rapid molecular confirmation and AFB culture provides definitive microbiological confirmation (though slowly), a needle biopsy provides histological confirmation. The finding of caseating granulomas in the pleural tissue is highly specific for tuberculosis. Given the options, and considering that histological evidence (granulomas) combined with potential microbiological analysis (AFB stain/culture on tissue) from the biopsy specimen is often considered a highly reliable method for confirming TB pleurisy, the needle biopsy is a strong candidate.
Therefore, a Needle Biopsy of the Pleura is often the investigation most likely to provide definitive pathological confirmation, especially when considering the combination of histological findings and the possibility of direct microbiological examination of the tissue.
Which of the following investigations may be used for the diagnosis of pulmonary tuberculosis?
1. Nucleic acid amplification
2. Culture in Middlebrook medium
3. Light emitting diode fluorescent microscopy with auramine staining
4. Peripheral blood smear
Select the correct answer using the code given below:
The most frequent adverse reaction of significance among people treated for drug-susceptible tuberculosis is:
All adult patients in whom anti-tubercular treatment is being started should undergo baseline assessment of: